Illumina

Manager Sales Specialists

California Twp, Michigan, United States

Illumina Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Genomics, Life SciencesIndustries

Requirements

Candidates should possess a Bachelor’s or Master’s degree in Life Sciences or an equivalent qualification, with a PhD being a plus. They are required to have at least 7 years of sales or customer-facing experience within the Life Science or Genomics industry.

Responsibilities

This role involves leading and managing a team of Multiomics/Sequencing Sales Specialists, developing and implementing territory plans to meet revenue quotas, overseeing team recruitment and development, ensuring customer satisfaction, monitoring market trends, training sales team members, controlling expenses, providing performance feedback, utilizing sales analytics tools, communicating regional business landscape, acting as a conduit for customer feedback, selling Illumina’s Multiomics vision and product offering, and participating in tradeshows and events.

Skills

Team Leadership
Sales Management
Bioinformatics
Genomic Technologies
Multiomics
Sequencing
Customer Relationship Management
Territory Planning
Business Development

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI